BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
68.63
-0.29 (-0.42%)
At close: Jun 23, 2026, 4:00 PM EDT
69.00
+0.37 (0.54%)
After-hours: Jun 23, 2026, 7:09 PM EDT
BridgeBio Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Maintains $125 → $98 | Buy | Maintains | $125 → $98 | +42.79% | Jun 17, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $106 → $96 | Buy | Maintains | $106 → $96 | +39.88% | Jun 15, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $101 | Buy | Maintains | $101 | +47.17% | Jun 11, 2026 |
| Barclays | Barclays | Buy Maintains $157 | Buy | Maintains | $157 | +128.76% | Jun 5, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Initiates $104 | Buy | Initiates | $104 | +51.54% | Jun 3, 2026 |
| Citi | Citi | Hold Maintains $82 | Hold | Maintains | $82 | +19.48% | Jun 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $110 | Buy | Reiterates | $110 | +60.28% | May 28, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $94 → $98 | Buy | Maintains | $94 → $98 | +42.79% | May 27, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.